Thomas P Miller

  • 19247 Citations
  • 57 h-Index
1978 …2016

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

The phenomenon of multidrug resistance in non-Hodgkin's lymphoma.

Miller, T. P., Chase, E. M., Dalton, W. S. & Grogan, T. M., 1996, In : Cancer treatment and research. 85, p. 107-117 11 p.

Research output: Contribution to journalReview article

6 Scopus citations

The presence of bcl-l and bci-2 gene rearrangements in diffuse small cleaved-cell lymphoma

Leith, C. P., Willman, C. L., Spier, C. M., Miller, T. P. & Grogan, T. M., Sep 1994, In : Diagnostic Molecular Pathology. 3, 3, p. 178-183 6 p.

Research output: Contribution to journalArticle

2 Scopus citations

The prognostic significance of the immunotype in diffuse large-cell lymphoma: A comparative study of the T-cell and B-cell phenotype

Lippman, S. M., Miller, T. P., Spier, C. M., Slymen, D. J. & Grogan, T. M., Jan 1 1988, In : Blood. 72, 2, p. 436-441 6 p.

Research output: Contribution to journalArticle

Open Access
113 Scopus citations

The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

Rosenwald, A., Wright, G., Wiestner, A., Chan, W. C., Connors, J. M., Campo, E., Gascoyne, R. D., Grogan, T. M., Muller-Hermelink, H. K., Smeland, E. B., Chiorazzi, M., Giltnane, J. M., Hurt, E. M., Zhao, H., Averett, L., Henrickson, S., Yang, L., Powell, J., Wilson, W. H., Jaffe, E. S. & 19 others, Simon, R., Klausner, R. D., Montserrat, E., Bosch, F., Greiner, T. C., Weisenburger, D. D., Sanger, W. G., Dave, B. J., Lynch, J. C., Vose, J., Armitage, J. O., Fisher, R. I., Miller, T. P., LeBlanc, M., Ott, G., Kvaloy, S., Holte, H., Delabie, J. & Staudt, L. M., Feb 2003, In : Cancer Cell. 3, 2, p. 185-197 13 p.

Research output: Contribution to journalArticle

692 Scopus citations

The reply

Grogan, T. M., Lippman, S. & Miller, T. P., Jan 1988, In : The American journal of medicine. 84, 1, p. 182-183 2 p.

Research output: Contribution to journalLetter

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

Rosenwald, A., Wright, G., Chan, W. C., Connors, J. M., Campo, E., Fisher, R. I., Gascoyne, R. D., Konrad Muller-Hermelink, H., Smeland, E. B., Giltnane, J. M., Hurt, E. M., Zhao, H., Averett, L., Yang, L., Wilson, W. H., Jaffe, E. S., Simon, R., Klausner, R. D., Powell, J., Duffey, P. L. & 20 others, Longo, D. L., Greiner, T. C., Weisenburger, D. D., Sanger, W. G., Dave, B. J., Lynch, J. C., Vose, J., Armitage, J. O., Montserrat, E., López-Guillermo, A., Grogan, T. M., Miller, T. P., Leblanc, M., Ott, G., Kvaloy, S., Delabie, J., Holte, H., Krajci, P., Stokke, T. & Staudt, L. M., Jun 20 2002, In : New England Journal of Medicine. 346, 25, p. 1937-1947 11 p.

Research output: Contribution to journalArticle

2774 Scopus citations

Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures

Mahadevan, D., Spier, C., Della Croce, K., Miller, S., George, B., Riley, C., Warner, S., Grogan, T. M. & Miller, T. P., Dec 1 2005, In : Molecular Cancer Therapeutics. 4, 12, p. 1867-1879 13 p.

Research output: Contribution to journalArticle

72 Scopus citations

Treatment of advanced breast cancer with mitomycin C combined with vinblastine or vindesine

Garewal, H. S., Brooks, R. J., Jones, S. E. & Miller, T. P., Jan 1 1983, In : Journal of Clinical Oncology. 1, 12, p. 772-775 4 p.

Research output: Contribution to journalArticle

33 Scopus citations

Treatment of diffuse large-cell lymphoma: a summary of outcome for patients treated by Southwest Oncology Group.

Miller, T. P. & Dahlberg, S., 1993, In : Cancer treatment and research. 66, p. 53-63 11 p.

Research output: Contribution to journalReview article

4 Scopus citations

Treatment of intermediate-grade and high-grade non-Hodgkin's lymphoma [1] (multiple letters)

Wirth, A., Prince, H. M., Wolf, M., Machida, U., Kami, M., Hirai, H., Mounier, N., Gisselbrecht, C., Lepage, E., Kosmas, C., Malamos, N. A., Antonopoulos, M. J., Decaudin, D., Miller, T., LeBlanc, M. & Fisher, R. I., Nov 12 1998, In : New England Journal of Medicine. 339, 20, p. 1475-1477 3 p.

Research output: Contribution to journalLetter

1 Scopus citations

Treatment of small-cell lung cancer with an alternating chemotherapy regimen given at weekly intervals: A Southwest Oncology Group pilot study

Taylor, C. W., Crowley, J., Williamson, S. K., Miller, T. P., Taylor, S. A., Giri, T. G. S., Stephens, R. L. & Livingston, R. B., Nov 1990, In : Journal of Clinical Oncology. 8, 11, p. 1811-1817 7 p.

Research output: Contribution to journalArticle

32 Scopus citations

Treatment of small cell lung cancer with VP-16, vincristine, doxorubicin (Adriamycin), cyclophosphamide (EVAC), and high-dose chest radiotherapy

Goodman, G. E., Miller, T. P., Manning, M. M., Davis, S. L. & McMahon, L. J., Jan 1 1983, In : Unknown Journal. 1, 8, p. 483-488 6 p.

Research output: Contribution to journalArticle

22 Scopus citations

Tumor-infiltrating T-lymphocytes in B-cell diffuse large cell lymphoma related to disease course.

Lippman, S. M., Spier, C. M., Miller, T. P., Slymen, D. J., Rybski, J. A. & Grogan, T. M., May 1990, In : Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 3, 3, p. 361-367 7 p.

Research output: Contribution to journalArticle

48 Scopus citations

Unfavorable histologies of non-Hodgkin's lymphoma treated with ProMACE-CytaBOM: A groupwide Southwest Oncology Group study

Miller, T. P., Dahlberg, S., Weick, J. K., Files, J. C., Eyre, H. J., Pendergrass, K. B. & Fisher, R. I., Dec 1990, In : Journal of Clinical Oncology. 8, 12, p. 1951-1958 8 p.

Research output: Contribution to journalArticle

49 Scopus citations

Utility of fine-needle aspiration as a diagnostic technique in lymphoma

Hehn, S. T., Grogan, T. M. & Miller, T. P., Dec 1 2004, In : Journal of Clinical Oncology. 22, 15, p. 3046-3052 7 p.

Research output: Contribution to journalReview article

167 Scopus citations

What is the treatment of choice for advanced-stage Hodgkin's lymphoma: ABVD, Stanford V, or BEACOPP?

Hehn, S. T. & Miller, T. P., Jan 2004, In : Current hematology reports. 3, 1, p. 17-26 10 p.

Research output: Contribution to journalReview article

10 Scopus citations

What should be the morphologic criteria for the subdivision of follicular lymphomas?

Nathwani, B. N., Metter, G. E., Miller, T. P., Burke, J. S., Mann, R. B., Barcos, M., Kjeldsberg, C. R., Dixon, D. O., Winberg, C. D. & Whitcomb, C. C., Jan 1 1986, In : Blood. 68, 4, p. 837-845 9 p.

Research output: Contribution to journalArticle

Open Access
55 Scopus citations